Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
PALI
#4213
Palisade Bio, Inc. Common Stock
1.940
0
USD
-4.43%
Settore:
Salute
Base:
USD
Valuta di Profitto:
USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-4.43%
Variazione Mensile
+14.12%
Variazione di 6 mesi
+14.12%
Variazione Annuale
+14.12%
Chiusura Precedente
2.030
0
Open
1.940
0
Bid
1.940
0
Ask
1.943
0
Low
1.940
0
High
1.940
0
Volume
48
Mercati
Mercato Azionario Statunitense
Salute
PALI
Open full chart
Financials
Overview
Estratto Conto
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
1.33 M
4.4 M
4.8 M
9.12 M
149 M
—
Valuation ratios
Enterprise value
-3.32 M
-2.56 M
-3.96 M
786.94 K
122.87 M
117.13 M
Price to earnings ratio
-0.28
-0.16
-0.14
-0.26
-0.64
-1.2
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
0.24
0.19
0.1
0.15
0.28
0.72
Price to book ratio
0.07
0.31
0.04
0.06
0.12
0.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.37
0.31
0.27
0.42
0.41
1.41
Return on equity %
0.53
0.45
0.42
1.06
0.89
2.82
Return on invested capital %
—
-1 413.39
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.31
3.24
2.84
1.62
1.96
9.67
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
-0.01
-0.01
-0.01
-0.04
-0.09
-0.15
Long term debt to total equity ratio
-0.01
-0.01
-0.01
-0.11
-0.19
-0.33
Per share metrics
Operating cash flow per share
2.68
1.68
0.49
0.38
0.62
3.17
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
6.85
6.92
1.5
1.13
0.92
10.46
Net current asset value per share
7.59
7.41
1.64
1.34
1.2
11.59
Tangible book value per share
5.65
5.29
1.11
0.55
0.56
7.51
Working capital per share
5.3
5.12
1.07
0.52
0.59
7.29
Book value per share
5.65
5.29
1.11
0.55
0.56
7.51
Notizie
Stifel avvia copertura su Palisade Bio con rating buy sul farmaco IBD
Stifel initiates Palisade Bio stock with buy rating on IBD drug
Palisade Bio presenta dati di trial su farmaco per colite ulcerosa a ECCO
Palisade Bio presents ulcerative colitis drug trial data at ECCO
Palisade Bio appoints IBD expert to clinical advisory board
Il direttore medico di Palisade Bio (PALI) Jones vende azioni per $3480
CEO di Palisade Bio Finley vende azioni per $6818
Palisade Bio nomina due esperti di IBD nel consiglio consultivo clinico
Palisade Bio appoints two IBD experts to clinical advisory board
Il direttore di Palisade Bio Williams acquista azioni per $9.400
Palisade Bio director Williams buys $9,400 in shares
B.Riley avvia copertura su Palisade Bio con rating Buy